Antimony Resources Corp. press release
Axcan Pharma to present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
CSE - Canadian National Stock Exchange · Antimony · Copper · Silver · Gold · Lead · Zinc · Uranium · Canada
TSX SYMBOL (Toronto Stock Exchange): AXP NASDAQ SYMBOL (NASDAQ National Market): AXCA
MONT SAINT-HILAIRE, QC, March 28 /CNW Telbec/ - Axcan Pharma Inc. ("Axcan" or the "Company") today announced that on Tuesday, April 4th, 2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an overview of the Company at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference to be held in New York, NY. This presentation will take place at 10:00 a.m. local time. A webcast of Axcan's presentation will also be accessible via the Company's website at www.axcan.com.
Axcan is a leading specialty pharmaceutical company involved in the field of gastroenterology. The Company markets a broad line of prescription products sold for the treatment of symptoms in a number of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to cystic fibrosis. Axcan's products are marketed by its own sales force in North America and Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".